Article info

Download PDFPDF
Twelve-month outcomes of ranibizumab versus aflibercept for macular oedema in branch retinal vein occlusion: data from the FRB! registry

Authors

  1. Correspondence to Dr Adrian R Hunt, Ophthalmology, Save Sight Institute, The University of Sydney, Sydney, NSW 2006, Australia; adrianhunt{at}eyesurgeonsmiranda.com.au
View Full Text

Citation

Hunt AR, Nguyen V, Creuzot-Garcher CP, et al
Twelve-month outcomes of ranibizumab versus aflibercept for macular oedema in branch retinal vein occlusion: data from the FRB! registry

Publication history

  • Received November 29, 2020
  • Revised February 12, 2021
  • Accepted March 4, 2021
  • First published March 12, 2021.
Online issue publication 
July 21, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.